API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.business-standard.com/article/companies/zydus-gets-dcgi-nod-for-drug-to-treat-anaemia-linked-with-kidney-disease-122030700301_1.html
https://www.biospace.com/article/releases/zydus-desidustat-shows-efficacy-and-safety-in-treating-hypoxia-in-hospitalized-covid-19-patients-in-mexico/
https://www.business-standard.com/article/news-cm/zydus-receives-usfda-approval-to-initiate-trials-of-desidustat-in-chemotherapy-induced-anemia-120072300339_1.html#:~:text=Zydus%20announced%20that%20it%20has,Chemotherapy%20Induced%20Anemia%20(CIA).&text=Desidustat%20is%20expected%20to%20increase,the%20cancer%20patients%20with%20CIA.
https://www.thehindubusinessline.com/companies/zydus-inks-pact-with-china-medical-system-to-market-desidustat-in-greater-china/article30607973.ece
https://www.biospectrumasia.com/news/39/13263/zydus-cadila-announces-phase-iii-trial-of-desidustat.html